| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 626876 | 2-Cyclopenten-1-one, 5-[(dimethylamino)methyl]-2-[2-[4- (2-methylpropyl)phenyl]propyl]-, hydrochloride | 0.0291420747327558 | 0.14597794 |
| NSC 642328 | Benzonitrile, 4-[[1,3,3a,4,9,9a-hexahydro-9-(4-hydroxy- 3,5-dimethoxyphenyl)-6,7-dimethoxy- 1-oxonaphtho[2,3-c]furan-4-yl]amino]-, [3aS-(3a.alpha.,4.beta.,9.alpha.,9a.beta.)]- (9CI) | 0.0291420747327558 | -0.079105237 |
| NSC 646395 | Null | 0.0291420747327558 | -0.032887299 |
| NSC 658398 | Ethyl 1-hydroxy-4-oxo-2,5-cyclohexadien-1-acetate | 0.0291420747327558 | 0.057052232 |
| NSC 664890 | Null | 0.0291420747327558 | 0.079232479 |
| NSC 665899 | Null | 0.0291420747327558 | 0.3043462 |
| NSC 670121 | 11-Hydroxy aclacinomycin A | 0.0291420747327558 | -0.17100047 |
| NSC 673499 | Null | 0.0291420747327558 | 0.27478321 |
| NSC 686551 | Null | 0.0291420747327558 | 0.26410064 |
| NSC 709358 | 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol | 0.029142074732756 | -0.12830497 |